Anyone who has had medical tests performed likely knows about Quest Diagnostics. The Secaucus-based company is perhaps the most prominent testing company in the world. Quest claims to serve one-third of U.S. adults each year, works with half of the nation’s physicians and hospitals, and employs a medical and scientific staff of more than 650 M.D.s and Ph.Ds. All of which produced revenue of nearly $11 billion in 2021, according to the company.
For podcast fans
NJBIZ Conversations is now available as a podcast, as well as a video. Subscribe to NJBIZ Conversations on Apple or Google Podcasts. Find direct links here: njbiz.podbean.com
During the early days of the COVID-19 pandemic, Quest played a crucial role in the effort to get ahead of the virus. Before vaccines and improved therapeutics, testing was really the only tool public health officials had to fight the outbreak — it was vital to identify where the virus was spreading and how quickly so that non-pharmaceutical intervention could at least slow the wildfire that threatened to consume New Jersey and other areas of the country. Remember “flatten the curve“?
For this edition of NJBIZ Conversations, Wendi Mader – Quest’s vice president of the commercial employer channel – talks about what it was like to play that role and discusses how she and her staff continue to help businesses identify and mitigate health risks faced by their employees.
To watch the interview, click on the image below.